Aomori (japan) Pharmaceutical LIMITED
Company Profile
AOMORI (JAPAN) PHARMACEUTICAL LIMITED is located at Rm K 3/F GOOD HARVEST CTR, 33 ON CHUEN ST, FAN LING, NEW TERRITORIES, HONG KONG. Operating in the Whol drugs/sundries industry, the company is registered as a corporation under the company number 1508820.
Aomori (japan) Pharmaceutical LIMITED
Rm K 3/F GOOD HARVEST CTR 33 ON CHUEN ST, , Fan Ling
1508820
Corporation
2010
Whol drugs/sundries
Aomori (japan) Pharmaceutical LIMITED
Rm K 3/F GOOD HARVEST CTR 33 ON CHUEN ST, , Fan Ling
1508820
Corporation
2010
Whol drugs/sundries
The revenue of Aomori (japan) Pharmaceutical LIMITED is $542 thousand
Aomori (japan) Pharmaceutical LIMITED: Revenue from 2017 to 2024
Revenue of AOMORI (JAPAN) PHARMACEUTICAL LIMITED: This data presents the revenue of AOMORI (JAPAN) PHARMACEUTICAL LIMITED from 2018 to 2010. In the fiscal year 2010, AOMORI (JAPAN) PHARMACEUTICAL LIMITED recorded a revenue of $614,878.67, showcasing its financial growth over recent years.
Revenue per year in USD ($)
Top 5 companies in revenue in Drugs, Drug Proprietaries, and Druggists' Sundries Worldwide
Company name | Sales |
---|---|
Cencora, Inc. | $262.2 billion |
Cardinal Health, Inc. | $205.0 billion |
McKesson Corporation | $276.7 billion |
PHOENIX Pharmahandel GmbH & Co KG | $38.6 billion |
Pfizer Service Company | $42.4 billion |
The number of employees of Aomori (japan) Pharmaceutical LIMITED is 1-4
Aomori (japan) Pharmaceutical LIMITED: Employees from 2017 - 2024
Employees at AOMORI (JAPAN) PHARMACEUTICAL LIMITED: AOMORI (JAPAN) PHARMACEUTICAL LIMITED now employs 6 people, reflecting the company’s significant presence.
Number of employees from 2017 to 2024
Global B2B Data in Bulk
Access the company database that sets the standard in scale and accuracy. Our massive B2B database covers all active companies worldwide, curated from trusted local sources. Delivered in bulk as CSV files.
The Industry of Aomori (japan) Pharmaceutical LIMITED is Drugs, Drug Proprietaries, and Druggists' Sundries
Aomori (japan) Pharmaceutical LIMITED Industry Data:
Industry of AOMORI (JAPAN) PHARMACEUTICAL LIMITED: AOMORI (JAPAN) PHARMACEUTICAL LIMITED operates in the Whol drugs/sundries industry, which falls under SIC Code 5122
Industry Statistics By Sic Code
Aomori (japan) Pharmaceutical LIMITED is operating in Sic Code:
Drugs, Drug Proprietaries, and Druggists' Sundries (5122) - Representation of companies operating in Australia/Asia and Hong Kong
919015
0.26% of companies worldwide
6897
0.36% of companies in HONG KONG
There are 919015 companies operating in this industry worldwide.
Buy in BulkBold Platform
The Bold platform provides instant access to verified data from active companies in 1,500 industries across 200+ countries, enabling users to find leads and download company lists in Excel.
Aomori (japan) Pharmaceutical LIMITED is solely 0 companies Worldwide
Ownership AOMORI (JAPAN) PHARMACEUTICAL LIMITED. AOMORI (JAPAN) PHARMACEUTICAL LIMITED established ownership in 2010 and operates independently with no additional companies in its corporate family structure. Registered as 3, this autonomy enables flexibility for swift decisions and unique strategies.
Company Type
Aomori (japan) Pharmaceutical LIMITED is registered as
153647093
44.07% of companies
1453130
75.43% of companies in HONG KONG
Bold Hierarchy
The Bold platform is your resource for Company Hierarchy Data, featuring insights on all companies connected across 200+ countries. Our database provides essential information about corporate structures, chains, and groups, empowering you to make informed, data-driven decisions.

Connect with Key Decision Makers at Aomori (japan) Pharmaceutical LIMITED
Email and Call Top Aomori (japan) Pharmaceutical LIMITED Contacts
AOMORI (JAPAN) PHARMACEUTICAL LIMITED operates with a small team, with a CEO registered at the official local trade register in HONG KONG. This compact team offers direct access to primary contacts and managers, including CIOs and HR managers, ensuring efficient communication with verified contact details.
Unlock Access to Key Personnel Contact Information on the Bold Platform Today!